Cargando…
Mechanisms of Therapeutic Resistance in Cancer (Stem) Cells with Emphasis on Thyroid Cancer Cells
The two main reasons for death of cancer patients, tumor recurrence and metastasis, are multi-stage cellular processes that involve increased cell plasticity and coincide with elevated resistance to anti-cancer treatments. Epithelial-to-mesenchymal transition (EMT) is a key contributor to metastasis...
Autores principales: | Hombach-Klonisch, Sabine, Natarajan, Suchitra, Thanasupawat, Thatchawan, Medapati, Manoj, Pathak, Alok, Ghavami, Saeid, Klonisch, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971176/ https://www.ncbi.nlm.nih.gov/pubmed/24723911 http://dx.doi.org/10.3389/fendo.2014.00037 |
Ejemplares similares
-
RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer
por: Thanasupawat, Thatchawan, et al.
Publicado: (2015) -
Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017) -
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells
por: Hombach‐Klonisch, Sabine, et al.
Publicado: (2018) -
Novel CTRP8‐RXFP1‐JAK3‐STAT3 axis promotes Cdc42‐dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells
por: Glogowska, Aleksandra, et al.
Publicado: (2021) -
Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling
por: Gaudreau-Lapierre, Antoine, et al.
Publicado: (2023)